AstraZeneca: FDA Committee Recommends Nirsevimab For RSV Lower Respiratory Tract Disease In Infants
LONDON (dpa-AFX) - British drug major AstraZeneca Plc (AZN, AZN.L) announced Friday that the US Food and Drug Administration Antimicrobial Drugs Advisory Committee or AMDAC has unanimously recommended